Aardvark Therapeutics, Inc. (AARD)
Nasdaq: AARD · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 |
|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 |
| Report filed | Mar 23, 2026 | Mar 31, 2025 |
| Revenue | 0 | · |
| For lenders | ||
| Interest and dividend income | 5,139 | 2,414 |
| Interest and investment income | 5,139 | 2,414 |
| Research and development | 48,936 | 17,363 |
| General and administrative | 13,789 | 5,305 |
| Total operating expenses | 62,725 | 22,785 |
| Operating income | -62,725 | -22,785 |
| Total non-operating income (expense) | 5,134 | 2,197 |
| Income tax expense | 0 | 0 |
| Net income | -57,591 | -20,588 |
| Earnings per share, basic | -2.93 | -5.15 |
| Earnings per share, diluted | -2.93 | -5.15 |
| Weighted average shares, basic | 19,624,626 | 3,996,376 |
| Weighted average shares, diluted | 19,624,626 | 3,996,376 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTaxInterest and dividend income what its loans and securities earned
us-gaap:InterestAndDividendIncomeOperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestAndDividendResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding